Alembic Ltd.

View in App
94.75 -1.00 ▼-1.0%

25 April 2024, 04:05:35 PM
Volume: 460,484

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembiclimited.com
Market Cap 2,434.81 Cr.
Enterprise Value(EV) 2,436.64 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 9.53 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 9.95 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 82.93 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.14 Calculated using Price: 94.82
Dividend Yield 2.32 Period Ending 2023-03
No. of Shares Subscribed 25.68 Cr. 256,781,828 Shares
FaceValue 2
About Alembic Ltd.
Alembic Ltd. is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharmaceuticals Ltd. and after the demerger, APL became the flagship company of the Alembic Group.

Alembic Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Alembic Ltd. Performance

View details >>
1 Day
-1.04%
1 Week
+1.28%
1 Month
+14.78%
3 Month
+3.44%
6 Month
+22.65%
1 Year
+57.65%
2 Year
+15.27%
5 Year
+123.20%
10 Year
+378.54%

Alembic Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 5.58 3.71 3.21 4.18 3.58 7.08 0.75 3.6 3.52
Return on Capital Employed (%) 3.82 3.82 3.12 4.44 3.91 7.12 0.94 4.1 3.82
Return on Assets (%) 2.88 3.25 2.94 3.88 3.39 6.8 0.71 3.42 3.33

Alembic Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 528 803 911 1,086 1,209 1,418 2,297 2,497 2,078 2,120
Non Curr. Liab. 38 15 13 14 9 7 53 68 43 50
Curr. Liab. 82 58 68 59 49 46 59 68 84 100
Minority Int.
Equity & Liab. 648 876 992 1,159 1,266 1,471 2,409 2,632 2,205 2,270
Non Curr. Assets 458 706 801 972 1,167 1,308 2,307 2,489 2,032 2,130
Curr. Assets 189 169 191 185 99 163 102 143 172 140
Misc. Exp. not W/O
Total Assets 648 876 992 1,159 1,266 1,471 2,409 2,632 2,205 2,270

Alembic Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 144 128 147 125 124 74 74 78 127 146
Other Income 22 29 31 37 30 94 11 89 64 55
Total Income 166 156 178 162 154 167 84 167 192 200
Total Expenditure -135 -122 -140 -114 -106 -71 -63 -64 -87 -99
PBIDT 30 35 38 48 48 97 21 103 105 101
Interest -1 0 0 0 0 0 0 0 0 -1
Depreciation -6 -6 -5 -4 -3 -3 -4 -5 -7 -8
Taxation 1 -1 1 -2 -4 0 -3 -12 -6 -5
Exceptional Items -3 -6 -11 -11
PAT 24 25 27 42 41 93 14 86 81 76
Minority Interest
Share Associate 82 210 118 121 172 236 329 136 110 168
Other Related Items
Consolidated Net Profit 107 235 145 163 213 329 343 222 191 245
Adjusted EPS 4 9 5 6 8 13 13 9 7 10

Alembic Ltd. Cash Flow

View details >>
Particulars 10 years 2010-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 149 22 10 52 24 22 7 -2 -18 39
Cash Fr. Inv. -24 5 -5 -47 -22 72 57 -35 19 7
Cash Fr. Finan. -118 -25 -5 -5 -3 -92 -6 -15 -6 -46
Net Change 7 2 0 0 -1 1 57 -52 -5 0
Cash & Cash Eqvt 24 3 2 2 1 2 59 6 1 1

Alembic Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88 70.88
Public 29.12 29.12 29.12 29.12 29.12 29.12 29.12 29.12 29.12
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Alembic Ltd. Announcements

View details >>
Thu, 25 Apr 2024
Loss/Duplicate-Share Certificate-XBRL
Alembic Limited has informed the Exchange about Loss of share certificates
Thu, 25 Apr 2024
Loss of Share Certificates
Alembic Limited has informed the Exchange about Loss of Share Certificates
Wed, 24 Apr 2024
Disclosure under SEBI Takeover Regulations
Chirayu Amin has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Alembic Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months

Alembic Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 +2.3%
Cipla Ltd. 113,471.29 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 +4.5%
Divi's Laboratories Ltd. 101,959.84 3,843.80 +0.8%
Zydus Lifesciences Ltd. 95,944.41 951.25 +1.9%
Mankind Pharma Ltd. 95,926.91 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 +1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 +1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 +1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 +1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 +1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 +1.6%

Alembic Ltd. FAQ's

What is Alembic share price?
Can I buy Alembic shares now?
What is the Dividend Yield of Alembic?
What is the Market Cap of Alembic?
What are the key metrics to analyse Alembic?
What is the 52 Week High and Low of Alembic?
What is the trend of Alembic share price?